Subplate neurons: potential targets for dysfunction after hypoxic-ischemic brain injury

Yi Wang1, Hong Cui2, Yi Wang2

  • 1Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, China; Department of Pediatrics, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Insights

Hypoxic-ischemic brain injury (HIBI) in children damages crucial subplate neurons. Targeting these vulnerable cells offers new therapeutic strategies for neurological repair and improved outcomes.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pediatric Neurology

Background:

  • Hypoxic-ischemic brain injury (HIBI) causes significant long-term neurological disability in children.
  • Current treatments for HIBI and its consequences are limited.
  • Neural circuit developmental disruption, including aberrant thalamocortical projections and loss of functional connectivity, underlies HIBI-related disabilities.

Purpose of the Study:

  • To review the vulnerability of subplate neurons (SPNs) to hypoxic-ischemic (HI) insult.
  • To examine the impact of SPN damage on neural circuitry development and function.
  • To explore neuroprotective strategies targeting SPNs for HIBI treatment.

Main Methods:

  • Literature review focusing on the role of subplate neurons in brain development.
  • Analysis of research on the effects of hypoxia-ischemia on neural circuits.
  • Synthesis of findings on potential therapeutic interventions targeting SPNs.

Main Results:

  • Subplate neurons are highly vulnerable to hypoxic-ischemic injury.
  • Damage to SPNs disrupts subcortical circuit integrity and functional network synchrony.
  • SPN dysfunction is a key mechanism in HIBI-related neurological deficits.

Conclusions:

  • Subplate neurons are critical for early neural network formation and are uniquely susceptible to HI injury.
  • Targeting SPN vulnerability presents a promising therapeutic avenue for mitigating HIBI-induced neurological damage.
  • Further research into SPN-focused neuroprotection could lead to improved clinical outcomes for affected children.